Profile data is unavailable for this security.
About the company
Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
- Revenue in USD (TTM)17.72m
- Net income in USD-3.37m
- Incorporated2006
- Employees168.00
- LocationSonoma Pharmaceuticals Inc5445 CONESTOGA COURT, SUITE 150BOULDER 80301United StatesUSA
- Phone+1 (617) 243-0050
- Fax+1 (707) 283-0551
- Websitehttps://sonomapharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LakeShore Biopharma Co Ltd | 89.13m | -14.49m | 2.47m | 573.00 | -- | 0.0172 | 0.371 | 0.0277 | -0.7499 | -0.7499 | 4.65 | 3.49 | 0.427 | 0.5001 | 1.30 | 155,549.80 | -6.94 | -- | -15.95 | -- | 82.47 | -- | -16.26 | -- | 0.7452 | -2.63 | 0.453 | -- | 7.24 | -- | 76.93 | -- | -- | -- |
| SOHM Inc | -100.00bn | -100.00bn | 2.71m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| China Pharma Holdings Inc | 4.05m | -3.19m | 2.76m | 224.00 | -- | 0.3322 | -- | 0.6816 | -1.10 | -1.10 | 1.28 | 1.66 | 0.2769 | 2.17 | 14.52 | 18,090.54 | -21.80 | -18.69 | -35.67 | -37.95 | -10.94 | -1.14 | -78.72 | -44.96 | 0.1026 | -30.50 | 0.2884 | -- | -35.41 | -16.15 | -53.84 | -- | 16.49 | -- |
| Jaguar Health Inc | 11.79m | -40.29m | 2.79m | 49.00 | -- | 0.7217 | -- | 0.2368 | -54.06 | -54.06 | 12.98 | 1.53 | 0.2184 | 0.2099 | 8.78 | 240,510.20 | -76.04 | -90.27 | -152.77 | -144.36 | 81.92 | 75.33 | -348.22 | -458.25 | 0.5197 | -4.62 | 0.8759 | -- | 19.75 | 15.14 | 6.80 | -- | -- | -- |
| 60 Degrees Pharmaceuticals Inc | 1.35m | -8.48m | 3.04m | 3.00 | -- | -- | -- | 2.24 | -23.04 | -23.04 | 2.93 | 4.32 | 0.1919 | 1.59 | 2.71 | 451,383.30 | -113.08 | -- | -148.26 | -- | 42.47 | -- | -589.17 | -- | 2.63 | -44.07 | 0.0342 | -- | 168.70 | -- | -111.48 | -- | -- | -- |
| Functional Brands Inc | 6.80m | -377.56k | 3.09m | 32.00 | -- | 2.22 | -- | 0.4551 | -0.0546 | -0.0546 | 0.9614 | 0.0854 | 0.8873 | 0.3527 | 37.24 | 212,408.80 | -4.93 | -- | -9.96 | -- | 91.06 | -- | -5.55 | -- | 0.4419 | -0.8723 | 0.6346 | -- | -3.72 | -- | 54.93 | -- | -- | -- |
| CYANOTECH CORP | 25.27m | -1.78m | 3.18m | 83.00 | -- | 0.3941 | 16.82 | 0.1258 | -0.2469 | -0.2469 | 3.51 | 1.09 | 1.05 | 2.21 | 12.81 | 304,433.80 | -7.41 | -6.08 | -13.42 | -8.05 | 32.00 | 32.26 | -7.03 | -6.37 | 0.2988 | -1.47 | 0.5089 | -- | 4.96 | -5.36 | 39.19 | -- | 1.97 | -- |
| Bio Essence Corp | 565.67k | -160.45k | 3.42m | 2.00 | -- | -- | -- | 6.05 | -0.0042 | -0.0042 | 0.0149 | -0.0816 | 1.26 | -- | 16.06 | 282,835.00 | -35.64 | -40.94 | -- | -- | 69.28 | 38.36 | -28.36 | -134.00 | -- | -57.42 | -- | -- | -- | -17.08 | -286.98 | -- | -- | -- |
| CASI Pharmaceuticals Inc | 26.85m | -49.38m | 4.43m | 233.00 | -- | -- | -- | 0.165 | -2.98 | -2.98 | 1.62 | -1.85 | 0.6096 | 1.60 | 4.22 | 115,218.90 | -107.02 | -36.27 | -277.91 | -51.90 | 53.68 | 57.36 | -175.56 | -124.01 | 0.236 | -13.27 | -- | -- | -15.77 | 47.19 | -45.62 | -- | -55.67 | -- |
| Sonoma Pharmaceuticals Inc | 17.72m | -3.37m | 4.76m | 168.00 | -- | 1.39 | -- | 0.2686 | -2.04 | -2.04 | 10.72 | 1.98 | 1.30 | 3.20 | 7.40 | 105,488.10 | -24.70 | -29.32 | -34.79 | -40.47 | 38.16 | 36.22 | -19.02 | -32.35 | 2.00 | -- | 0.00 | -- | 12.19 | -4.44 | 28.50 | -- | -17.24 | -- |
| Sunshine Biopharma Inc | 37.32m | -5.99m | 5.59m | 52.00 | -- | 0.2147 | -- | 0.1499 | -2.03 | -2.03 | 10.74 | 5.31 | 1.21 | 2.09 | 10.12 | 717,764.30 | -19.47 | -68.65 | -23.80 | -89.02 | 33.01 | 32.79 | -16.06 | -81.12 | 2.09 | -209.95 | 0.00 | -- | 44.75 | 340.11 | -13.94 | -- | 370.33 | -- |
| Holder | Shares | % Held |
|---|---|---|
| DRW Securities LLCas of 31 Dec 2025 | 60.98k | 3.59% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 18.79k | 1.10% |
| Geode Capital Management LLCas of 31 Dec 2025 | 15.91k | 0.94% |
| McKinley Carter Wealth Services, Inc.as of 31 Dec 2025 | 11.19k | 0.66% |
| Global Retirement Partners LLCas of 31 Dec 2025 | 772.00 | 0.05% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2025 | 500.00 | 0.03% |
| Tower Research Capital LLCas of 31 Dec 2025 | 385.00 | 0.02% |
| JPMorgan Securities LLC (Investment Management)as of 31 Dec 2025 | 121.00 | 0.01% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 113.00 | 0.01% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 100.00 | 0.01% |
